Evidence map›Paper›PMID 25873395›Full record

ArticleThe Journal of biological chemistry2015

Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Mart Reimund, Mikael Larsson, Oleg Kovrov, Sergo Kasvandik, Gunilla Olivecrona, Aivar Lookene

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Structure of lipoprotein lipase in complex with GPIHBP1.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mart ReimundFrom the Department of Chemistry, Tallinn University of Technology, Tallinn 12618, Estonia.
Mikael Larssonthe Department of Medical Biosciences, Umeå University, SE-901 87 Umeå, Sweden, and.
Oleg Kovrovthe Department of Medical Biosciences, Umeå University, SE-901 87 Umeå, Sweden, and.
Sergo Kasvandikthe Institute of Technology, University of Tartu, Tartu 50411, Estonia.
Gunilla Olivecronathe Department of Medical Biosciences, Umeå University, SE-901 87 Umeå, Sweden, and.
Aivar LookeneFrom the Department of Chemistry, Tallinn University of Technology, Tallinn 12618, Estonia, aivar.lookene@ttu.ee.
Umeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GPIHBP1 is an endothelial membrane protein that transports lipoprotein lipase (LPL) from the subendothelial space to the luminal side of the capillary endothelium. Here, we provide evidence that two regions of GPIHBP1, the acidic N-terminal domain and the central Ly6 domain, interact with LPL as two distinct binding sites. This conclusion is based on comparative binding studies performed with a peptide corresponding to the N-terminal domain of GPIHBP1, the Ly6 domain of GPIHBP1, wild type GPIHBP1, and the Ly6 domain mutant GPIHBP1 Q114P. Although LPL and the N-terminal domain formed a tight but short lived complex, characterized by fast on- and off-rates, the complex between LPL and the Ly6 domain formed more slowly and persisted for a longer time. Unlike the interaction of LPL with the Ly6 domain, the interaction of LPL with the N-terminal domain was significantly weakened by salt. The Q114P mutant bound LPL similarly to the N-terminal domain of GPIHBP1. Heparin dissociated LPL from the N-terminal domain, and partially from wild type GPIHBP1, but was unable to elute the enzyme from the Ly6 domain. When LPL was in complex with the acidic peptide corresponding to the N-terminal domain of GPIHBP1, the enzyme retained its affinity for the Ly6 domain. Furthermore, LPL that was bound to the N-terminal domain interacted with lipoproteins, whereas LPL bound to the Ly6 domain did not. In summary, our data suggest that the two domains of GPIHBP1 interact independently with LPL and that the functionality of LPL depends on its localization on GPIHBP1.

Indexed as

AnimalsAnisotropyBinding SitesCattleCross-Linking ReagentsEndothelium, VascularEpitopesFluorescent DyesGlycosylphosphatidylinositolsHeparinHumansHydrogen-Ion ConcentrationLipoprotein LipaseLipoproteinsMass SpectrometryMiceCross-Linking ReagentsEpitopesFluorescent DyesGlycosylphosphatidylinositolsGPIHBP1 protein, humanGPI-HBP1 protein, mouseHeparinLipoprotein LipaseLipoproteinsPeptidesReceptors, LipoproteinGPIHBP1kineticslipoprotein lipaselipoprotein metabolismprotein cross-linkingprotein-protein interactionsurface plasmon resonance (SPR)

Identifiers

PMID25873395
PMCPMC4447966
OpenAlexW2080112974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.